153 related articles for article (PubMed ID: 34199044)
21. Contribution of Electrocardiogram in the Differentiation of Cardiac Amyloidosis and Nonobstructive Hypertrophic Cardiomyopathy.
Huang J; Zhao S; Chen Z; Zhang S; Lu M
Int Heart J; 2015; 56(5):522-6. PubMed ID: 26346516
[TBL] [Abstract][Full Text] [Related]
22. Gender differences and the electrocardiogram in left ventricular hypertrophy.
Okin PM; Roman MJ; Devereux RB; Kligfield P
Hypertension; 1995 Feb; 25(2):242-9. PubMed ID: 7843774
[TBL] [Abstract][Full Text] [Related]
23. Electrocardiogram voltage discordance: Interpretation of low QRS voltage only in the precordial leads.
Kim DH; Verdino RJ
J Electrocardiol; 2017; 50(5):551-554. PubMed ID: 28495230
[TBL] [Abstract][Full Text] [Related]
24. QRS voltage of the electrocardiogram and Frank vectorcardiogram in relation to ventricular volume.
Talbot S; Kilpatrick D; Jonathan A; Raphael MJ
Br Heart J; 1977 Oct; 39(10):1109-13. PubMed ID: 143949
[TBL] [Abstract][Full Text] [Related]
25. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult.
Domingues K; Saraiva M; Marta L; Monteiro I; Leal M
Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998
[TBL] [Abstract][Full Text] [Related]
26. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
[TBL] [Abstract][Full Text] [Related]
27. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis.
Zhao L; Li J; Tian Z; Fang Q
J Cardiol; 2016 Nov; 68(5):426-430. PubMed ID: 26685729
[TBL] [Abstract][Full Text] [Related]
28. A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
Zhang KW; Zhang R; Deych E; Stockerl-Goldstein KE; Gorcsan J; Lenihan DJ
Am Heart J; 2021 Feb; 232():137-145. PubMed ID: 33212046
[TBL] [Abstract][Full Text] [Related]
29. [Cardiac progression of systemic light chain amyloidosis].
Chango Azanza DX; Fernández Tirado RL; López Pillaga VV; Tello Ochoa JD; Pinos Vásquez JF
Arch Peru Cardiol Cir Cardiovasc; 2022; 3(4):220-225. PubMed ID: 37284565
[TBL] [Abstract][Full Text] [Related]
30. Cardiac amyloidosis in a patient with multiple myeloma: a case report and review of literature.
Sedaghat D; Zakir RM; Choe J; Klapholz M; Saric M
J Clin Ultrasound; 2009; 37(3):179-84. PubMed ID: 19177424
[TBL] [Abstract][Full Text] [Related]
31. Increased QRS voltage in the limb leads.
MacKenzie R
J Insur Med; 2006; 38(3):213-9. PubMed ID: 17076143
[TBL] [Abstract][Full Text] [Related]
32. [The rapid progress of heart failure due to systemic amyloidosis with cardiac involvement--case report].
Gilowski W; Stryjewski P; Gilowska M; Liszniański P; Nowak J
Przegl Lek; 2015; 72(11):697-700. PubMed ID: 27012134
[TBL] [Abstract][Full Text] [Related]
33. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis.
Yuda S; Hayashi T; Yasui K; Muranaka A; Ohnishi H; Hashimoto A; Ishida T; Tsuchihashi K; Shinomura Y; Watanabe N; Miura T
Intern Med; 2015; 54(15):1833-40. PubMed ID: 26234222
[TBL] [Abstract][Full Text] [Related]
34. Simple criteria for differentiation of Fabry disease from amyloid heart disease and other causes of left ventricular hypertrophy.
Hoigné P; Attenhofer Jost CH; Duru F; Oechslin EN; Seifert B; Widmer U; Frischknecht B; Jenni R
Int J Cardiol; 2006 Aug; 111(3):413-22. PubMed ID: 16307805
[TBL] [Abstract][Full Text] [Related]
35. ECG identification of left ventricular hypertrophy. Relationship of test performance to body habitus.
Okin PM; Roman MJ; Devereux RB; Kligfield P
J Electrocardiol; 1996; 29 Suppl():256-61. PubMed ID: 9238409
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity.
Okin PM; Roman MJ; Devereux RB; Kligfield P
J Am Coll Cardiol; 1996 Jan; 27(1):124-31. PubMed ID: 8522685
[TBL] [Abstract][Full Text] [Related]
37. Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy.
Dollar AL; Roberts WC
Am J Med; 1989 Oct; 87(4):377-81. PubMed ID: 2529761
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of the frontal QRS-T angle in patients with AL cardiac amyloidosis.
Medvedovsky AT; Pollak A; Shuvy M; Gotsman I
J Electrocardiol; 2020; 59():122-125. PubMed ID: 32062381
[TBL] [Abstract][Full Text] [Related]
39. [Augmentation of left ventricular outflow tract gradient by digitalis glycosides in a case of cardiac (AL-) amyloidosis].
Petzsch M; Pulya K; Anders O
Dtsch Med Wochenschr; 2001 Aug; 126(33):909-12. PubMed ID: 11514926
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of electrocardiographic criteria in echocardiographic diagnosis of different patterns of left ventricular hypertrophy.
Oikonomou E; Theofilis P; Mpahara A; Lazaros G; Niarchou P; Vogiatzi G; Tsalamandris S; Fountoulakis P; Christoforatou E; Mystakidou V; Anastasiou M; Goliopoulou A; Tousoulis D
Ann Noninvasive Electrocardiol; 2020 May; 25(3):e12728. PubMed ID: 31724804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
